Your browser doesn't support javascript.
loading
Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.
Schmidt, Kim E; Kuepper, Janina M; Schumak, Beatrix; Alferink, Judith; Hofmann, Andrea; Howland, Shanshan W; Rénia, Laurent; Limmer, Andreas; Specht, Sabine; Hoerauf, Achim.
Affiliation
  • Schmidt KE; Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.
  • Kuepper JM; Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.
  • Schumak B; Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.
  • Alferink J; Department of Psychiatry and Psychotherapy, University Hospital Muenster, Muenster, Germany.
  • Hofmann A; Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.
  • Howland SW; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
  • Rénia L; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
  • Limmer A; Clinic for Anaesthesiology and Intensive Care, University Hospital Essen, Essen, Germany.
  • Specht S; Institutes of Molecular Medicine and Experimental Immunology, University Hospital Bonn, Bonn, Germany.
  • Hoerauf A; Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.
PLoS One ; 13(2): e0192717, 2018.
Article in En | MEDLINE | ID: mdl-29438386

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Malaria, Cerebral / Doxycycline / Antimalarials Type of study: Prognostic_studies Limits: Animals Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2018 Document type: Article Affiliation country: Germany Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Malaria, Cerebral / Doxycycline / Antimalarials Type of study: Prognostic_studies Limits: Animals Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2018 Document type: Article Affiliation country: Germany Country of publication: United States